Pediatrics
Service
Karolinska Institute
Estocolmo, SueciaPublications in collaboration with researchers from Karolinska Institute (17)
2024
-
Higher COVID-19 pneumonia risk associated with anti-IFN-α than with anti-IFN-ω auto-Abs in children
The Journal of experimental medicine, Vol. 221, Núm. 2
2023
2022
-
A genome-wide association study with tissue transcriptomics identifies genetic drivers for classic bladder exstrophy
Communications Biology, Vol. 5, Núm. 1
-
Exome-wide association study to identify rare variants influencing COVID-19 outcomes: Results from the Host Genetics Initiative
PLoS genetics, Vol. 18, Núm. 11, pp. e1010367
-
Improving empiric antibiotic prescribing in pediatric bloodstream infections: a potential application of weighted-incidence syndromic combination antibiograms (WISCA)
Expert Review of Anti-Infective Therapy, Vol. 20, Núm. 3, pp. 445-456
2021
-
Treatment of Multisystem Inflammatory Syndrome in Children
New England Journal of Medicine, Vol. 385, Núm. 1, pp. 11-22
2020
-
Simplifying the clinical classification of polymerase gamma (POLG) disease based on age of onset; studies using a cohort of 155 cases
Journal of Inherited Metabolic Disease, Vol. 43, Núm. 4, pp. 726-736
-
The impact of gender, puberty, and pregnancy in patients with POLG disease
Annals of Clinical and Translational Neurology, Vol. 7, Núm. 10, pp. 2019-2025
2019
-
Newborn screening for homocystinurias: Recent recommendations versus current practice
Journal of Inherited Metabolic Disease, Vol. 42, Núm. 1, pp. 128-139
2017
-
Assessment of continuous pain in newborns admitted to NICUs in 18 European countries
Acta Paediatrica, International Journal of Paediatrics, Vol. 106, Núm. 8, pp. 1248-1259
-
ISL1 is a major susceptibility gene for classic bladder exstrophy and a regulator of urinary tract development
Scientific Reports, Vol. 7
2015
-
Sedation and analgesia practices in neonatal intensive care units (EUROPAIN): Results from a prospective cohort study
The Lancet Respiratory Medicine, Vol. 3, Núm. 10, pp. 796-812
2014
-
Birthweight and the risk of atopic diseases: The ISAAC Phase III study
Pediatric Allergy and Immunology, Vol. 25, Núm. 3, pp. 264-270
2012
-
Safety of a 2-dose regimen of a combined measles, mumps, rubella and varicella live vaccine manufactured with recombinant human albumin
Pediatric Infectious Disease Journal, Vol. 31, Núm. 11, pp. 1166-1172
2011
-
Global analysis of breast feeding and risk of symptoms of asthma, rhinoconjunctivitis and eczema in 6-7 year old children: ISAAC Phase Three
Allergologia et Immunopathologia, Vol. 39, Núm. 6, pp. 318-325